Possible cholestatic injury from ranitidine with a review of the literature

American Journal of Gastroenterology

Volumn 93, Issue 5, 1998, Pages 822-826

  Ramrakhiani, Sanjay ^a   Brunt, Elizabeth M ^a   Bacon, Bruce R ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXMETIDINE; RANITIDINE;

ADULT; ARTICLE; CASE REPORT; CHOLESTASIS; CHOLESTATIC HEPATITIS; HEPATITIS; HUMAN; HUMAN TISSUE; JAUNDICE; LIVER BIOPSY; LIVER TOXICITY; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; CHOLESTASIS, INTRAHEPATIC; HEPATITIS, TOXIC; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; RANITIDINE;

EID: 0032081001     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.233_a.x     Document Type: Article

References (23)

1. 1. Zeldis JB, Friedman LS, Isselbacher KJ. Ranitidine: A new H2-receptor antagonist. N Engl J Med 1983;309:1368-73.
2. 2. Helfrich HM, Evers PW, Schriver RC, et al. Role of nocturnal acid suppression on the rate of duodenal ulcer healing: Clinical dose-range trials with oxmetidine. Am J Gastroenterol 1985;80:959-63.
3. 3. Boyd MR. Toxicity mediated by reactive metabolites of furans. Adv Exp Med Biol 1980;136B:856-79.
4. 4. Wilson RA, Hall T, Hart J. Oxmetidine (H2 receptor antagonist) induced cytotoxicity in isolated rat hepatocytes. J Appl Toxicol 1988; 8:223-5.
5. 5. Zimmerman HJ, Jacob L, Bassan H, et al. Effects of H2 blocking agents on hepatocytes in vitro: Correlation with potential for causing hepatic disease in patients. Proc Soc Exp Biol Med 1986;182: 511-4.
6. 6. Jack D, Smith RN. Hepatitis associated with ranitidine. JAMA 1984; 252:3253-4 (letter).
7. 7. Inman WHW. A preliminary study of Zantac (ranitidine). PEM News 1983;1:9-13.
8. 8. Dobbs JH, Muir JG, Smith RN. H2 antagonists and hepatitis. Ann Intern Med 1986;105:803 (letter).
9. 9. Barr GD, Piper DW. Possible ranitidine hepatitis. Med J Aus 1981;2: 421.
10. 10. Halparin LS. Adverse effects of ranitidine therapy. Can Med Assoc J 1984;130:668-72 (letter).
11. 11. Offit K, Sojka DA. Ranitidine. N Engl J Med 1984;310:1603 (letter).
12. 12. Lauritsen K, Havelund T, Rask-Madsen J. Ranitidine and hepatotoxicity. Lancet 1984;ii:1471 (letter).
13. 13. Bredfeldt JE, von Huene C. Ranitidine, acetaminophen and hepatotoxicity. Ann Intern Med 1984;101:719 (letter).
14. 14. Black M, Scott WE Jr., Kanter R. Possible ranitidine hepatotoxicity. Ann Intern Med 1984;101:208-10.
15. 15. Souza Lima MA. Hepatitis associated with ranitidine. Ann Intern Med 1984;101:207-8.
16. 16. Proctor JD. Hepatitis associated with ranitidine. JAMA 1984;251:1554 (letter).
17. 17. Hiesse C, Cantarovich M, Santelli C, et al. Ranitidine hepatotoxicity in renal transplant patient. Lancet 1985;1:1280 (letter).
18. 18. Karachalios GN. Ranitidine and hepatitis. Ann Intern Med 1985;103: 634-5 (letter).
19. 19. Graham DY, Opekun AR, Smith JL, et al. Ranitidine and hepatotoxicity. Ann Intern Med 1985;102:416 (letter).
20. 20. Lewis JH et al. Hepatic effects of drugs used in the treatment of peptic ulcer disease. Am J Gastroenterol 1987;82:987-1003.
21. 21. Cherqui B, Desaint B, Legendre C, et al. [Fatal hepatitis in a female patient treated with ranitidine (letter)]. [French] Gastroenterologie Clinique et Biologique 1989;13:952-3.
22. 22. Souza Lima MA. Ranitidine and the liver. Ann Intern Med 1985;102: 273-4.
23. 23. Farrell GC. Drug-induced liver disease. Edinburgh: Churchill Living-stone, 1994: 1-673.